Enovis Corporation

NYSE:ENOV Rapporto sulle azioni

Cap. di mercato: US$2.6b

Enovis Gestione

Gestione criteri di controllo 3/4

Enovis Il CEO è Matt Trerotola, nominato in Jul2015, e ha un mandato di 9.33 anni. la retribuzione annua totale è $ 10.77M, composta da 10% di stipendio e 90% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.32% delle azioni della società, per un valore di $ 8.31M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.8 anni e 4.3 anni.

Informazioni chiave

Matt Trerotola

Amministratore delegato

US$10.8m

Compenso totale

Percentuale dello stipendio del CEO10.0%
Mandato del CEO9.3yrs
Proprietà del CEO0.3%
Durata media del management5.8yrs
Durata media del Consiglio di amministrazione4.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

Sep 24
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

It's A Story Of Risk Vs Reward With Enovis Corporation (NYSE:ENOV)

Aug 20
It's A Story Of Risk Vs Reward With Enovis Corporation (NYSE:ENOV)

Enovis Languishing Despite Respectable Performance

Jul 15

Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

Jun 07
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

Enovis: Solid Growth, But Unstable Financial Footing

May 05

Enovis Corporation (NYSE:ENOV) Might Not Be As Mispriced As It Looks

Apr 22
Enovis Corporation (NYSE:ENOV) Might Not Be As Mispriced As It Looks

Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)

Feb 12
Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)

Is Enovis (NYSE:ENOV) Using Too Much Debt?

Jan 14
Is Enovis (NYSE:ENOV) Using Too Much Debt?

Investors Holding Back On Enovis Corporation (NYSE:ENOV)

Dec 18
Investors Holding Back On Enovis Corporation (NYSE:ENOV)

Calculating The Fair Value Of Enovis Corporation (NYSE:ENOV)

Nov 05
Calculating The Fair Value Of Enovis Corporation (NYSE:ENOV)

Enovis Making Good Choices, But Not Seeing The Rewards

Sep 27

Is Enovis (NYSE:ENOV) A Risky Investment?

Sep 22
Is Enovis (NYSE:ENOV) A Risky Investment?

Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)

Aug 03
Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)

Enovis Corporation: Things Are Looking Good As Guidance Is Raised

Jul 18

We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt

Jun 20
We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt

Enovis Corporation Q4 2022 Earnings Preview

Feb 22

Is Enovis (NYSE:ENOV) A Risky Investment?

Feb 22
Is Enovis (NYSE:ENOV) A Risky Investment?

Is Enovis Corporation (NYSE:ENOV) Worth US$60.5 Based On Its Intrinsic Value?

Jan 25
Is Enovis Corporation (NYSE:ENOV) Worth US$60.5 Based On Its Intrinsic Value?

Enovis Corporation reports Q3 earnings beat; updates FY22 guidance

Nov 02

Is Enovis (NYSE:ENOV) A Risky Investment?

Oct 19
Is Enovis (NYSE:ENOV) A Risky Investment?

Is Enovis Corporation (NYSE:ENOV) Trading At A 27% Discount?

Sep 14
Is Enovis Corporation (NYSE:ENOV) Trading At A 27% Discount?

Enovis launches augmented reality system ARVIS for use in hip, knee surgery

Jul 19

Here's Why Enovis (NYSE:ENOV) Can Manage Its Debt Responsibly

Jul 05
Here's Why Enovis (NYSE:ENOV) Can Manage Its Debt Responsibly

Enovis announces CFO transition

Jun 30

Enovis: Medtech Leftover Of Colfax With Some To Prove

May 23

As The Colfax Chapter Ends, Both ESAB And Enovis Have Something To Prove

Apr 05

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Matt Trerotola rispetto agli utili di Enovis?
DataCompenso totaleStipendioGuadagni aziendali
Sep 27 2024n/an/a

-US$121m

Jun 28 2024n/an/a

-US$107m

Mar 29 2024n/an/a

-US$103m

Dec 31 2023US$11mUS$1m

-US$54m

Sep 29 2023n/an/a

-US$112m

Jun 30 2023n/an/a

-US$159m

Mar 31 2023n/an/a

-US$23m

Dec 31 2022US$12mUS$1m

-US$39m

Sep 30 2022n/an/a

US$1m

Jul 01 2022n/an/a

US$54m

Apr 01 2022n/an/a

-US$109m

Dec 31 2021US$14mUS$1m

-US$103m

Oct 01 2021n/an/a

-US$48m

Jul 02 2021n/an/a

-US$18m

Apr 02 2021n/an/a

US$21m

Dec 31 2020US$8mUS$1m

-US$75m

Oct 02 2020n/an/a

US$53m

Jul 03 2020n/an/a

US$39m

Apr 03 2020n/an/a

US$42m

Dec 31 2019US$8mUS$1m

US$8m

Sep 27 2019n/an/a

US$10m

Jun 28 2019n/an/a

US$21m

Mar 29 2019n/an/a

US$66m

Dec 31 2018US$3mUS$1m

US$108m

Sep 28 2018n/an/a

-US$115m

Jun 29 2018n/an/a

-US$84m

Mar 30 2018n/an/a

-US$92m

Dec 31 2017US$3mUS$1m

US$28m

Compensazione vs Mercato: La retribuzione totale di Matt ($USD 10.77M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 6.60M ).

Compensazione vs guadagni: La retribuzione di Matt è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Matt Trerotola (57 yo)

9.3yrs

Mandato

US$10,774,635

Compensazione

Mr. Matthew L. Trerotola, also known as Matt, has been the Chief Executive Officer of Enovis Corporation (formerly known as Colfax Corporation) since July 24, 2015 and had been its President from July 2015...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Matthew Trerotola
CEO & Chairman9.3yrsUS$10.77m0.32%
$ 8.3m
Phillip Berry
Senior VP & CFO1.8yrsUS$2.36m0.063%
$ 1.6m
Patricia Lang
Senior VP & Chief Human Resources Officer5.8yrsUS$2.07m0.040%
$ 1.0m
Daniel Pryor
Executive Vice President of Strategy & Business Development11.3yrsUS$4.75m0.15%
$ 4.0m
Brady Shirley
Executive Advisor & Director8yrsUS$5.20m0.11%
$ 2.9m
John Kleckner
VP, Controller & Chief Accounting Officer2.5yrsNessun dato0.012%
$ 300.6k
Derek Leckow
Vice President of Investor Relationsno dataNessun datoNessun dato
Bradley Tandy
Senior VP & Chief Legal Officer5.8yrsNessun dato0.045%
$ 1.2m
Katie Sweet
Vice President of Corporate Communicationno dataNessun datoNessun dato
Tim Czartoski
President of U.S. Surgical and Global Product & Enabling Technologiesless than a yearNessun datoNessun dato
Terry Ross
Group President Prevention & Recoveryno dataNessun dato0.035%
$ 912.2k
Brian Hanigan
Secretaryno dataNessun datoNessun dato

5.8yrs

Durata media

56.5yo

Età media

Gestione esperta: Il team dirigenziale di ENOV è esperto e expertise (durata media dell'incarico 5.8 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Matthew Trerotola
CEO & Chairman9.3yrsUS$10.77m0.32%
$ 8.3m
Brady Shirley
Executive Advisor & Director2.6yrsUS$5.20m0.11%
$ 2.9m
Sharon Wienbar
Lead Independent Director8.4yrsUS$316.46k0%
$ 0
A. Perfall
Independent Director14.2yrsUS$308.93k0.0044%
$ 115.1k
Angela Lalor
Independent Director2.6yrsUS$296.46k0.022%
$ 562.9k
Rajiv Vinnakota
Independent Director16.5yrsUS$298.93k0.039%
$ 1.0m
Liam Kelly
Independent Director4.8yrsUS$283.93k0.023%
$ 603.3k
Philip Okala
Independent Director3.8yrsUS$283.93k0.015%
$ 383.0k
Barbara Bodem
Independent Director2.6yrsUS$283.93k0.015%
$ 383.0k
Christine Ortiz
Independent Director2.6yrsUS$283.93k0.015%
$ 383.0k

4.3yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ENOV sono considerati esperti (durata media dell'incarico 4.3 anni).